We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Angi Inc
ANGI
$198M
| $254K | ﹤0.01% |
4,324
+820
| +23% | +$48.4K |
|
2702
Marcus & Millichap
MMI
$1.2B
| $254K | ﹤0.01% |
+6,780
| New | +$242K |
|
|
TSYS
2703
DELISTED
TELECOMMUNICATIONS SYS INC "A"
TSYS
| $254K | ﹤0.01% |
66,402
+3,200
| +5% | +$10.2K |
|
|
SSE
2704
DELISTED
SEVENTY SEVEN ENERGY INC COM
SSE
| $253K | ﹤0.01% |
60,931
+17,605
| +41% | +$78.2K |
|
|
CBK
2705
DELISTED
Christopher & Banks Corporation
CBK
| $252K | ﹤0.01% |
45,276
+6,800
| +18% | +$36.1K |
|
|
RNDY
2706
DELISTED
ROUNDYS INC COM STK
RNDY
| $251K | ﹤0.01% |
51,390
+2,600
| +5% | +$11K |
|
2707
Lexicon Pharmaceuticals
LXRX
$1.07B
| $250K | ﹤0.01% |
37,818
+6,715
| +22% | +$45.9K |
|
2708
Moelis & Co
MC
$5.06B
| $250K | ﹤0.01% |
8,295
-100
| -1% | -$3.16K |
|
|
SHYF
2709
DELISTED
The Shyft Group
SHYF
| $250K | ﹤0.01% |
51,517
+2,300
| +5% | +$11.9K |
|
|
SPNS
2710
DELISTED
Sapiens International
SPNS
| $250K | ﹤0.01% |
30,465
+2,000
| +7% | +$14.8K |
|
|
BEAT
2711
DELISTED
BioTelemetry, Inc.
BEAT
| $250K | ﹤0.01% |
28,215
+2,500
| +10% | +$25.3K |
|
2712
DMC Global
BOOM
$155M
| $249K | ﹤0.01% |
19,507
+1,075
| +6% | +$15.7K |
|
2713
LSI Industries
LYTS
$909M
| $249K | ﹤0.01% |
30,552
+1,400
| +5% | +$10.3K |
|
|
ZIXI
2714
DELISTED
Zix Corporation
ZIXI
| $249K | ﹤0.01% |
63,286
+11,200
| +22% | +$42.4K |
|
|
OCLR
2715
DELISTED
Oclaro Inc.
OCLR
| $249K | ﹤0.01% |
125,689
+6,300
| +5% | +$10.5K |
|
2716
Alpha and Omega Semiconductor
AOSL
$1B
| $248K | ﹤0.01% |
27,826
+1,400
| +5% | +$12.5K |
|
2717
Paycom
PAYC
$9.92B
| $248K | ﹤0.01% |
+7,745
| New | +$230K |
|
|
WMAR
2718
DELISTED
West Marine Inc
WMAR
| $248K | ﹤0.01% |
26,736
+1,200
| +5% | +$13.8K |
|
|
RGLS
2719
DELISTED
Regulus Therapeutics
RGLS
| $247K | ﹤0.01% |
121
+34
| +39% | +$73.9K |
|
2720
Saga Communications
SGA
$60.5M
| $247K | ﹤0.01% |
5,536
+300
| +6% | +$12.5K |
|
|
HEOP
2721
DELISTED
Heritage Oaks Bancorp
HEOP
| $247K | ﹤0.01% |
29,735
+1,500
| +5% | +$12.1K |
|
|
DSCI
2722
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $247K | ﹤0.01% |
29,174
+1,500
| +5% | +$12.8K |
|
2723
Agilysys
AGYS
$3.01B
| $246K | ﹤0.01% |
24,998
+1,000
| +4% | +$10.4K |
|
|
ESIO
2724
DELISTED
Electro Scientific Industries
ESIO
| $246K | ﹤0.01% |
39,793
+1,600
| +4% | +$10.8K |
|
|
ADPT
2725
DELISTED
Adeptus Health Inc
ADPT
| $246K | ﹤0.01% |
+4,890
| New | +$193K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.